Vol. 14 No. 4 (2021)

• In Memory of Academician V.G. Savchenko

  399-401

  • PDF_2021-14-4-399-401 (Russian)

INTERVIEWS

• Low-Risk Myelodysplastic Syndromes

  Sergei Vasilevich Gritsaev

  403-413

  • PDF_2021-14-4-403-413 (Russian)

EXPERIMENTAL STUDIES

• Acute Myeloid Leukemia Patient-Derived Xenograft Models Generated with the Use of Immunodeficient NSG-SGM3 Mice

  Ekaterina Viktorovna Baidyuk, E.V. Belotserkovskaya, L.L. Girshova, V.A. Golotin, K.A. Levchuk, M.L. Vasyutina, Ya.A. Portnaya, E.V. Shchelina, O.G. Bredneva, A.V. Petukhov, A.Yu. Zaritskey, O.N. Demidov

  414-425

  • PDF_2021-14-4-414-425 (Russian)

• Following an Article Published in This Issue (a Letter to the Editors)

  А.А. Shtil

  426

  • PDF_2021-14-4-426 (Russian)

REVIEWS

• Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

  Ekaterina Yurevna Chelysheva, M.A. Guryanova, A.G. Turkina

  427-435

  • PDF_2021-14-4-427-435 (Russian)

• Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review

  Aleksandra Vladimirovna Semyanikhina, E.E. Tolstykh

  436-443

  • PDF_2021-14-4-436-443 (Russian)

• Langerhans Cell Histiocytosis in Adults: Treatment Opportunities of Today

  Vitalii Dmitrievich Latyshev, E.A. Lukina

  444-454

  • PDF_2021-14-4-444-454 (Russian)

LYMPHOID TUMORS

• Results of the Russian Multi-Center Cooperative Prospective-Retrospective Observational Program for Hodgkin’s Lymphoma Treatment RNWOHG-HD1

  Ivan Sergeevich Moiseev, S.M. Alekseev, N.B. Mikhailova, K.D. Kaplanov, M.V. Demchenkova, L.V. Anchukova, V.V. Baikov, A.M. Belyaev, Yu.A. Vasil’eva, N.P. Volkov, Yu.N. Vinogradova, A.Yu. Zaritskey, A.E. Zdorov, N.V. Il’in, L.O. Kashintseva, E.V. Kondakova, P.V. Kotselyabina, V.A. Lapin, K.V. Lepik, I.V. Lesechko, V.M. Moiseenko, G.M. Manikhas, N.V. Medvedeva, Yu.A. Oleinik, E.S. Pavlyuchenko, K.S. Parfenova, E.V. Patrakova, A.V. Proidakov, D.V. Saidullaeva, E.V. Tarasova, A.L. Shipaeva, T.V. Shneider, B.V. Afanasyev

  455-465

  • PDF_2021-14-4-455-465 (Russian)

• Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

  Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin

  466-476

  • PDF_2021-14-4-466-476 (Russian)

• Systemic Т-Cell Lymphoproliferative Disease Associated with Epstein-Barr Virus: A Literature Review and a Case Report

  E.A. Shalamova, Alla Mikhailovna Kovrigina, I.A. Shupletsova, E.E. Nikulina, V.D. Latyshev, N.V. Tsvetaeva

  477-487

  • PDF_2021-14-4-477-487 (Russian)

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  • PDF_2021-14-4-488-495 (Russian)

• Carmustine in the Therapy of B-Cell Lymphomas

  Daria Aleksandrovna Koroleva, E.E. Zvonkov

  496-502

  • PDF_2021-14-4-496-502 (Russian)

MYELOID TUMORS

• Technical Aspects of Minimal Residual Disease Detection by Multicolor Flow Cytometry in Acute Myeloid Leukemia Patients

  I.V. Galtseva, Yuliya Olegovna Davydova, N.M. Kapranov, K.A. Nikiforova, E.N. Parovichnikova

  503-512

  • PDF_2021-14-4-503-512 (Russian)

NEWS

• Treatment Opportunities in Relapsed Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphomas (Resolution of Expert Panel)

  513-514

  • PDF_2021-14-4-513-514 (Russian)